Ebos Group (ASX:EBO) Construction In Progress: A$0 Mil (As of Dec. 2025)


ASX:EBO Ebos Group Ltd ASX:EBO
77 GF Score
Price A$16.76
GF Value A$31.49
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ebos Group Construction In Progress?

Ebos Group ASX:EBO +0.30% 77 Construction In Progress is A$0 Mil as of Dec. 2025. GuruFocus rates ASX:EBO with a GF Score™ of 77/100 and a GF Value™ of A$31.49 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Ebos Group's quarterly construction in progress increased from Dec. 2024 (A$0 Mil) to Jun. 2025 (A$120 Mil) but then declined from Jun. 2025 (A$120 Mil) to Dec. 2025 (A$0 Mil).

Ebos Group's annual construction in progress increased from Jun. 2023 (A$49 Mil) to Jun. 2024 (A$62 Mil) and increased from Jun. 2024 (A$62 Mil) to Jun. 2025 (A$120 Mil).

Ebos Group Construction In Progress Historical Data

* Premium members only.

The historical data trend for Ebos Group's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ebos Group Construction In Progress Chart

Ebos Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.28 25.05 48.85 62.19 120.06

Ebos Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 62.19 0.00 120.06 0.00
ASX:EBO
77GF Score
Ebos Group Ltd ASX:EBO
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ebos Group Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of A$0 Mil mean?
Ebos Group (ASX:EBO) has a Construction In Progress of A$0 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Ebos Group and its competitors.
Is Ebos Group's Construction In Progress too high?
Ebos Group's current Construction In Progress is A$0 Mil. Overall, Ebos Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's Construction In Progress compare to MCK and COR?
Ebos Group's Construction In Progress of A$0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Distribution company?
A good Construction In Progress depends on the Medical Distribution industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Ebos Group and its competitors. Ebos Group's current Construction In Progress is A$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$31.49, compared to a current price of A$16.76 — trading 46.8% below its estimated fair value. The current Construction In Progress is A$0 Mil. Ebos Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current Construction In Progress is A$0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ebos Group (ASX:EBO) Overvalued in 2026?

Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued. The current stock price of A$16.76 is trading 46.8% below its estimated GF Value™ of A$31.49. GuruFocus considers Ebos Group to be Significantly Undervalued.

Key valuation signals for ASX:EBO:

  • Construction In Progress: A$0 Mil
  • GF Value™: A$31.49 vs. price of A$16.76 (46.8% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ebos Group Business Description

Address 737 Bourke Street, Level 7, Docklands, Melbourne, VIC, AUS, 3008
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
77GF Score

Get the complete analysis for ASX:EBO

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$16.76
Price
A$31.49
GF Value